Detect Brain Injuries in 15 Minutes

Revolutionary point-of-care diagnostic device that saves lives by detecting traumatic brain injuries before CT scans

15-minute results
100X cheaper than CT
96.5% accuracy
Neural Protein: Normal Brain Marker: Elevated Result: TBI Detected

How Bio-Stride Works

Simple, fast, and accurate brain injury detection in 4 easy steps

1

Collect Blood Sample

Simple fingerstick or venous draw - only 20μL required (smaller than a drop)

2

Insert Test Cartridge

Place cartridge in device - our sensors detect brain injury biomarkers automatically

3

Wait 15 Minutes

Our AI algorithms analyze biomarker levels and process results in real-time

4

Get Clear Results

Receive definitive indication whether CT scan is needed - saving critical time

Applications Across Healthcare

Transforming brain injury diagnosis for every care setting

🏥

Hospitals & Emergency Departments

Reduce CT scan backlogs and improve patient flow in emergency departments

  • Faster triage decisions
  • Reduced radiation exposure
  • Cost-effective screening
🚑

Ambulances & Pre-Hospital Care

Enable early brain injury detection during the golden hour of care

  • On-site testing capability
  • Better hospital preparation
  • Improved patient outcomes
🏘️

Rural Clinics & Remote Areas

Bring advanced diagnostics to underserved communities

  • No specialist required
  • Reduces need for transfers
  • Affordable for any clinic

Why Bio-Stride?

Transforming emergency diagnostics with cutting-edge technology

15-Minute Results

Rapid TBI detection from just 1μL of blood, enabling critical decisions in the golden hour

💰

100X Cheaper

₹1.5L device vs ₹1.5Cr CT scan, making advanced diagnostics accessible to all

🔬

FDA-Validated Biomarkers

Using proven GFAP and UCH-L1 biomarkers for accurate, reliable results

📱

Portable & Rugged

Designed for ambulances and field use, operational in extreme conditions

☁️

Cloud Analytics

Real-time data sharing and AI-powered insights for better patient outcomes

🏥

Modular Platform

Expandable to detect multiple conditions - stroke, cardiac markers, organ failure

The Critical Challenge

When someone suffers a head injury, rapid assessment is crucial. Undetected traumatic brain injury leads to paralysis, neurological disorders, and death.

In India, with only 0.55 hospital beds per 1,000 people and 75% of infrastructure in urban areas, rural patients face average travel distances over 100km to reach CT scan facilities. This delay during the critical golden hour often results in permanent disability.

4M
Emergency visits/year in India due to falls
6hrs
Average wait time for CT scan at AIIMS
75%
Healthcare infrastructure in urban areas
100km
Average rural distance to healthcare

The Reality of Brain Injury Emergency Care

🚨

Emergency Arrival

Patient arrives with head injury

30min - 6hrs Wait

For CT scan availability

Bio-Stride: 15min

Rapid diagnosis at bedside

Breakthrough Technology

Patent-pending electrochemical detection validated at BITS Pilani

How Bio-Stride Works

1

Blood Sample Collection

Fingerstick or venous draw - only 20μL required

2

Biomarker Detection

Electrochemical sensors biomarkers

3

Signal Processing

Embedded algorithms analyze biomarker concentrations

4

Clinical Decision Support

Clear indication of CT scan necessity within 15 minutes

Technical Specifications

  • Detection Range: 47-10,000 pg/mL
  • Sensitivity: 96.5% clinical sensitivity
  • Analysis Time: < 15 minutes
  • Sample Volume: 20μL whole blood
  • Battery Life: >4 hours continuous use
  • Connectivity: Bluetooth, Wi-Fi, 4G/5G

Technical Specifications

Specification Details
Detection Method Electrochemical biosensor with proprietary signal processing
Sample Volume 20μL whole blood (finger prick)
Detection Range 47–10,000 pg/mL
Time to Result < 15 minutes
Sensitivity 96.5% clinical sensitivity
Specificity 92% clinical specificity
Operating Temperature 5°C to 45°C
Device Dimensions 20cm × 15cm × 8cm (portable handheld)
Battery Life >4 hours continuous use
Connectivity Bluetooth, Wi-Fi, 4G/5G, offline capability

Bio-Stride vs. Traditional Methods

See how we're transforming TBI diagnosis with innovative technology

CT Scan

₹1.5 Cr
  • Equipment cost
  • 2–4 hours total time
  • Requires hospital infrastructure
  • Radiation exposure

Clinical Observation

₹0
  • 24–48 hours observation
  • May miss mild TBI
  • Requires hospital stay
  • Subjective assessment
🏆 Patent Pending

Protected Innovation

Our proprietary Portable Point-of-Care Diagnostic System for Early Detection of Traumatic Brain Injury using Blood Biomarkers is protected under Indian Patent Application (filed July 2025).

What Healthcare Professionals Say

Real feedback from leading medical professionals in Jaipur's premier hospitals

"

There is an urgent need for an objective TBI detection method beyond the subjective Glasgow Coma Scale. The device would be especially useful with venous blood samples in emergency settings during the golden hour.

Dr. Bhawani Shankar Mishra

Deputy General Manager & DNB Program Coordinator
Eternal Hospital (EHCC), Jaipur
23 years clinical practice • 125+ clinical trials

"

The device would be especially useful in primary and secondary hospitals lacking on-site neurosurgeons, to guide timely transfers. I'm willing to trial the device for 15–30 days in my department.

Dr. Vishuddha Kaushal

Head of Department & Senior Consultant
Emergency Medicine, Eternal Hospital (EHCC), Jaipur

"

Only 20–30% of head-injury CT scans actually confirm TBI. An objective test would be highly valued to reduce unnecessary scans and help persuade patients to seek surgery sooner when indicated.

Dr. Akshay Kumar Mangal

Associate Consultant
Neuro & Spine Surgery, Fortis Hospital, Jaipur

"

Only about 2% of CT scans for head injury actually find a TBI in our hospital. Small private hospitals would benefit most—where a quick TBI test could guide whether to transfer patients to higher centers.

Dr. Swati Joshi

Professor of Radiology
Mahatma Gandhi Medical College & Hospital, Jaipur

"

50–60% of head injury CT scans are effectively unnecessary. A rapid test could help screen out minor cases. The device should be as simple as a glucometer—enabling use by any ER staff with minimal training.

Dr. Yugal Dutt

Senior Resident, Emergency Department
Narayana Hospital, Jaipur

"

Treating TBI within the first hour is critical—mortality roughly doubles after the first hour without intervention. Position the device as an adjunct to CT scans, not a replacement, to make it acceptable to the medical community.

Dr. V. D. Sinha

Former HOD of Neurosurgery
SMS Medical College & Hospital, Jaipur

"

The device should be portable and usable by nurses or paramedics in pre-hospital settings. Primary health centers could use it to convince families to accept referral by providing tangible evidence of brain injury.

Dr. Gaurav Bhargava

Head of Emergency Department
CK Birla Hospital, Jaipur

"

Getting a CT scan done can take 1 to 1.5 hours even in a city hospital. About 40% of smaller hospitals in Jaipur have no CT scanner. A bedside TBI device would be great, especially at night. I'd enthusiastically pilot this device.

Dr. Sanjeev Sharma

Consultant Neurosurgeon
Bhandari Hospital, Jaipur

View All Testimonials

Clinical Validation Results

Survey of 10 senior medical professionals across Jaipur's leading hospitals

100%

Confirmed urgent need for rapid TBI assessment

₹300-1000

Willing to pay per test cartridge

30min-6hrs

Current CT scan wait times

100%

Expressed interest to pilot the technology

Frequently Asked Questions

Everything you need to know about Bio-Stride's TBI diagnostic technology

How accurate is Bio-Stride compared to CT scans? +
Bio-Stride demonstrates 96.5% clinical sensitivity and 92% specificity in detecting traumatic brain injuries. While CT scans remain the gold standard for imaging brain structures, Bio-Stride serves as a crucial screening tool to determine whether a CT scan is necessary, potentially reducing unnecessary radiation exposure and healthcare costs.
How does the device detect brain injuries? +
Bio-Stride uses proprietary electrochemical sensor technology to detect specific proteins released into the bloodstream when brain cells are damaged. Our device analyzes these neurological injury markers in a tiny blood sample, providing an objective indication of traumatic brain injury within 15 minutes of collection. The technology is based on clinically validated biomarkers approved by regulatory authorities.
How much does each test cost? +
Based on our survey of healthcare professionals, the target price is ₹300-₹1,000 per test cartridge, which is significantly more cost-effective than CT scans (₹1,500-₹3,000+ in private hospitals). The device itself costs approximately ₹1.5L, making it 100X cheaper than CT machines (₹1.5Cr+).
Can nurses or paramedics operate the device? +
Yes, Bio-Stride is designed to be operated by trained nurses and paramedics without requiring specialized medical expertise. The device features an intuitive interface and automated testing protocols, making it ideal for use in ambulances, emergency departments, and rural clinics where specialists may not be immediately available.
How does this help rural healthcare providers? +
Rural providers often lack access to CT scanners and neurosurgical expertise. Bio-Stride enables them to quickly determine if a patient needs to be transferred to a higher-level facility for emergency brain surgery, reducing unnecessary transfers while ensuring critical cases receive timely care. This is especially important given India's healthcare infrastructure challenges.
What regulatory approvals are needed? +
Bio-Stride will require CDSCO (Central Drugs Standard Control Organisation) approval in India before commercial deployment. We are currently conducting clinical validation studies and preparing regulatory submission documents. The device uses FDA-validated biomarkers, which should facilitate the approval process.
When will the device be available for purchase? +
We are currently in the clinical validation phase and expect to begin pilot programs with select healthcare facilities in 2025. Following successful clinical trials and regulatory approval, commercial availability is projected for 2026. Interested healthcare providers can register for early access programs and pilot testing opportunities.
How does Bio-Stride help during the "golden hour"? +
The "golden hour" refers to the critical first hour after brain injury when prompt intervention can save lives and prevent permanent disability. Bio-Stride provides results in 15 minutes, allowing healthcare providers to make crucial treatment decisions quickly. This is especially valuable in ambulances and emergency departments where every minute counts for patient outcomes.
What makes Bio-Stride different from existing diagnostic methods? +
Unlike subjective assessments like the Glasgow Coma Scale, Bio-Stride provides objective, quantitative results. It can detect brain injuries that may not show up on initial CT scans, such as diffuse axonal injuries. The device requires only a tiny blood sample (20μL), works in 15 minutes, and costs 100X less than CT machines while being completely portable.
How can Bio-Stride reduce unnecessary CT scans? +
Studies show that 50-70% of head injury CT scans show no significant findings. Bio-Stride can serve as an initial screening tool to identify which patients truly need CT imaging. This reduces radiation exposure (especially important for children), saves healthcare costs, and frees up CT resources for patients who actually need them, while still ensuring no critical cases are missed.
Is Bio-Stride suitable for pediatric cases? +
Yes, Bio-Stride is particularly valuable for pediatric head injuries. Many physicians are cautious about ordering CT scans for children due to radiation risks. Bio-Stride offers a radiation-free screening method that can help determine whether a CT scan is truly necessary for a child, potentially reducing unnecessary radiation exposure while ensuring appropriate care.
How does the device work in resource-limited settings? +
Bio-Stride is specifically designed for resource-limited settings. It's portable, battery-powered, requires minimal training, and costs significantly less than CT scanners. This makes it ideal for rural clinics, primary health centers, and smaller hospitals that lack neuroimaging facilities. The device can help these facilities make informed decisions about patient transfers to higher-level care centers.
Can Bio-Stride help with patient family communication? +
Yes, having an objective test result can significantly help doctors communicate the severity of a brain injury to patients and families. This is especially valuable when convincing patients to accept transfer to specialized care or undergo necessary surgery. The concrete, quantitative result provides clear evidence that supports medical recommendations and treatment decisions.

Innovation Team

Award-winning researchers from India's premier institutions

Led by Anagh Sinha

BITS Pilani | Electronics Engineering & Biological Science Dual Major

Our team combines expertise from BITS Pilani, AIIMS, and IISER. We've conducted award-winning research at the University of Tokyo and ETH Zurich (QS #7 globally) on diagnostic systems.

IIE Invent Award Amgen Research Fellowship University of Tokyo Best Poster 2024 ETH Zurich Research 2 Successful Startup Exits

Learn More About Bio-Stride

Explore our technology, team, and clinical research

Experience the Future of Emergency Diagnostics

See how Bio-Stride can transform emergency care in your organization

Schedule a Demo

Get in Touch

Join us in revolutionizing emergency diagnostics

Contact Information

contact@biostridedx.com
+91 77-268-521-36
Shri Niwas Mill, Near Vivekanand Sanskar School, Sawai Madhopur, Gangapur City, Rajasthan, 322201, India